INND (Innerscope Hearing Technologies) Beta: 1.4260 (As of Jun. 26, 2026)


What is Innerscope Hearing Technologies Beta?

Innerscope Hearing Technologies INND -2.78% Beta is 1.4260 as of Jun. 26, 2026.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Innerscope Hearing Technologies's Beta is 1.4260.

Innerscope Hearing Technologies  (OTCPK:INND) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Innerscope Hearing Technologies Beta Related Terms

Innerscope Hearing Technologies Beta Historical Data

* Premium members only.

The historical data trend for Innerscope Hearing Technologies's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innerscope Hearing Technologies Beta Chart

Innerscope Hearing Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 51.73

Innerscope Hearing Technologies Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.86 2.34 2.16 51.73

INND vs NWCN, NCAP, MOBQ: Beta Comparison

For the Medical Instruments & Supplies subindustry, Innerscope Hearing Technologies's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innerscope Hearing Technologies Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innerscope Hearing Technologies's Beta distribution charts can be found below:

* The bar in red indicates where Innerscope Hearing Technologies's Beta falls into.


Innerscope Hearing Technologies Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.4260 mean?
Innerscope Hearing Technologies (INND) has a Beta of 1.4260 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Innerscope Hearing Technologies and its competitors.
Is Innerscope Hearing Technologies' Beta too high?
Innerscope Hearing Technologies' current Beta is 1.4260.
How does Innerscope Hearing Technologies' Beta compare to NWCN and NCAP?
Innerscope Hearing Technologies' Beta of 1.4260 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Innerscope Hearing Technologies and its competitors. Innerscope Hearing Technologies's current Beta is 1.4260. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innerscope Hearing Technologies stock overvalued right now?
Innerscope Hearing Technologies (INND) has a current Beta of 1.4260. The current Beta is 1.4260. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Innerscope Hearing Technologies (INND), the current Beta is 1.4260 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innerscope Hearing Technologies Business Description

Address 2151 Professional Drive, Suite 105, Roseville, CA, USA, 95661
Innerscope Hearing Technologies Inc is a manufacturer and distributor of OTC Hearing Aids, Hearing Aid Accessories & Hearing Health-Related Products (Hearing Products) dedicated to addressing the demand for affordable hearing solutions. The company operates retail hearing device clinics in California. InnerScope is focused on leveraging these strategic assets to identify, incubate, and support health-technology ventures positioned for growth in public markets and long-term shareholder value creation.